$16.42
-$0.93
(-5.36%)
Quote as of 3:27 PM EST on 02/10/12
Theravance, Inc.
NASDAQ:THRX
|
$16.42
-$0.93
(-5.36%)
|
|
| Today's Open | $16.61 |
|---|---|
| Previous Close | $17.35 |
| Daily Range | $15.69 - $16.85 |
| 52-Week Range | $12.91 - $28.95 |
| Market Cap | $1.40B |
| P/E Ratio | -12.31 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 602,646 |
| Average Daily Volume | 753,568 |
| Current FY EPS | -$1.35 |
THRX Information
| Description |
|---|
| A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Theravance Shares Tanked: What You Need to Know
Investors: 1 Dividend to Buy, 1 Dividend to Sell
Glaxo and Theravance Suffer Setback - Analyst Blog
Glaxo and Theravance Suffer Setback - Analyst Blog
Glaxo Plans Filing Advair Replacement Relovair In Mid-2012
CORRECT: Glaxo Plans Filing Advair Replacement Relovair In Mid-2012
Theravance Shares Got Crushed: What You Need to Know
Here's What 1 of the Best Investors Is Buying
Risk-Reward Balanced at Theravance - Analyst Blog
Smart Money Picks: Biotech Stocks With Bullish Short Trends
